NCT06575322 Effects of Neoadjuvant Therapy With Carboplatin, Paclitaxel Combined With Anti-PD-1 Drugs on Pain, Anxiety and Depression in Patients With Resectable Head and Neck Squamous Cell Carcinoma
| NCT ID | NCT06575322 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University |
| Condition | Head and Neck Squamous Cell Carcinoma |
| Study Type | OBSERVATIONAL |
| Enrollment | 302 participants |
| Start Date | 2024-09-01 |
| Primary Completion | 2026-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 302 participants in total. It began in 2024-09-01 with a primary completion date of 2026-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to learn about the Effects of neoadjuvant therapy with carboplatin, paclitaxel combined with anti-PD-1 drugs on pain, anxiety and depression in patients with operable head and neck squamous cell carcinoma: a prospective cohort study
Eligibility Criteria
Inclusion Criteria: \- 1: Clinical diagnosis of head and neck squamous cell carcinoma (stage I-IVA), without prior treatment, and planning to undergo either surgical treatment alone or surgical treatment combined with chemotherapy and immunotherapy. 2: Ability to speak Chinese and possess basic reading and writing skills. Exclusion Criteria: * 1: Presence of mental illnesses such as dementia or delirium. 2: Active use of narcotic drugs, including consuming alcohol more than 4 times per day or more than 4 times per week. 3: Patients who alter their treatment plan during the course of treatment. 4: Current or prior use of antidepressants.
Contact & Investigator
Song Fan, Doctor
STUDY CHAIR
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Frequently Asked Questions
Who can join the NCT06575322 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Head and Neck Squamous Cell Carcinoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06575322 currently recruiting?
Yes, NCT06575322 is actively recruiting participants. Contact the research team at fansong2@mail.sysu.edu.cn for enrollment information.
Where is the NCT06575322 trial being conducted?
This trial is being conducted at Guanzhou, China.
Who is sponsoring the NCT06575322 clinical trial?
NCT06575322 is sponsored by Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University. The principal investigator is Song Fan, Doctor at Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University. The trial plans to enroll 302 participants.